Canton Strategic Holdings, Inc.

CNTN

Healthcare Biotechnology

EPS
+85.9%
Free cash flow
−600.4%

Quarter to June 2026, against a year earlier

2.06 0.13 +6.74%
Market cap
$164.1M
P/E
n/m
Fwd P/E
—
Dividend yield
—
F-score
n/a
ROIC
−8.11%
Net debt / EBITDA
0.8×
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
ROE

+8 more TTM periods

(225.01%) (17.99%) (34.42%) (43.10%)
ROA
(159.36%) (13.74%) (27.53%) (34.60%)
ROIC
0.00% (3.26%) (7.94%) (8.11%)
Return on Tangible Assets
(167.66%) (254.73%) (192.44%) (254.25%)
Free Cash Flow per Share
(1.40) (0.50) (0.10) (0.10)
Free Cash Flow
(8.72) (16.13) (21.07) (22.17)
Other line items

Show all line items

Columns are period end dates · fundamentals updated 26 Oct 2026